Rad57 inhibitors are a class of chemical compounds specifically designed to target and inhibit the function of Rad57, a protein involved in DNA repair, particularly in the homologous recombination pathway. Rad57, together with Rad55, forms a heterodimer that interacts with the Rad51 recombinase complex, facilitating the search for homologous DNA sequences and promoting strand exchange during DNA repair. Homologous recombination is a critical mechanism for maintaining genomic stability, as it repairs double-strand breaks (DSBs) in DNA by using a homologous sequence as a template. Rad57 acts as a mediator in this process, enhancing the stability and activity of Rad51 filaments on single-stranded DNA. Inhibitors of Rad57 function by disrupting its ability to form complexes with Rad55 and Rad51, or by interfering with its binding to DNA, thereby impairing the efficiency of the homologous recombination process.
The inhibition of Rad57 can lead to significant consequences for cellular genomic stability. By blocking Rad57's involvement in homologous recombination, these inhibitors impede the cell's ability to repair double-strand DNA breaks accurately, potentially resulting in an accumulation of DNA damage. This disruption in the DNA repair process can affect cell cycle progression, genomic integrity, and overall cell survival, as homologous recombination is essential for the precise repair of DNA damage. Researchers utilize Rad57 inhibitors to study the specific role of Rad57 in DNA repair and to explore how its interaction with other proteins, like Rad55 and Rad51, contributes to maintaining genomic stability. These inhibitors provide valuable insights into the broader mechanisms of DNA repair, particularly the homologous recombination pathway, and the ways in which Rad57 and its associated protein complexes safeguard genetic information during replication and after DNA damage. Understanding Rad57's role through the use of inhibitors helps to uncover the intricacies of DNA repair pathways and their impact on cellular health and genome maintenance.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Olaparib | 763113-22-0 | sc-302017 sc-302017A sc-302017B | 250 mg 500 mg 1 g | $206.00 $299.00 $485.00 | 10 | |
PARP inhibitor, impacts the base excision repair pathway which can indirectly affect homologous recombination. | ||||||
Rucaparib | 283173-50-2 | sc-507419 | 5 mg | $150.00 | ||
Another PARP inhibitor, with similar effects on DNA repair pathways as Olaparib. | ||||||
RAD51 Inhibitor B02 | 1290541-46-6 | sc-507533 | 10 mg | $95.00 | ||
Inhibitor of RAD51, a key protein in homologous recombination, which is linked to Rad57. | ||||||
MRN-ATM Pathway Inhibitor, Mirin | 299953-00-7 | sc-203144 | 10 mg | $138.00 | 4 | |
Inhibits Mre11-Rad50-Nbs1 (MRN) complex, indirectly impacting the homologous recombination repair. | ||||||
DNA-PK Inhibitor II | 154447-35-5 | sc-202143 sc-202143A | 10 mg 50 mg | $155.00 $660.00 | 6 | |
Inhibits DNA-PK, which can lead to impaired non-homologous end joining and indirectly influence homologous recombination. | ||||||
VE 821 | 1232410-49-9 | sc-475878 | 10 mg | $360.00 | ||
ATR inhibitor, influencing DNA damage response and indirectly affecting Rad57 functions. | ||||||
ATM Kinase Inhibitor | 587871-26-9 | sc-202963 | 2 mg | $108.00 | 28 | |
ATM kinase inhibitor, affecting DNA damage response. | ||||||
NU 7441 | 503468-95-9 | sc-208107 | 5 mg | $350.00 | 10 | |
Another DNA-PK inhibitor, similar in action to NU7026. | ||||||
AZD-0156 | 1821428-35-6 | sc-507529 | 10 mg | $280.00 | ||
ATM inhibitor, impacting DNA damage response and Rad57-associated pathways. | ||||||
PARP Inhibitor VIII, PJ34 | 344458-15-7 | sc-204161 sc-204161A | 1 mg 5 mg | $57.00 $139.00 | 20 | |
Another PARP inhibitor, influencing the base excision repair pathway. | ||||||